Analyst Profile

Followed by 123 followers
.
Justin Zelin

Justin Zelin

BTIG
Wall Street Analyst
#6,931 out of 8,160 Wall Street Analysts
#20,679 out of 24,427 experts

Success Rate

45%
50 out of 111 transactions made a profit

Average Return

-4.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
Copying Justin Zelin's trades since 2020 and holding each position for 1 Year would result in 45.05% of your transactions generating a profit, with an average return of -4.0% per rating.

Stock Rating Distribution

146Ratings
100.00% Buy
0.00% Hold
0.00% Sell
Distribution of Justin Zelin's ratings

Additional Information

Main Sector:General
Geo Coverage:
United StatesUS Market

Best Rating

Stock:
Bellus Health Inc.
(BLU)
Rating:Buy
Date:Aug 24, 2021 - Aug 24, 2022
Return:+243.30%
The most profitable rating made by Justin Zelin

Justin Zelin's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
NightHawk Biosciences
Nov 11, 2020
Buy
Reiterated
$28.00
(2077.29% Upside)
3Ratings
0%
-34.00%
Geron
Nov 11, 2020
Buy
Reiterated
$4.00
(73.91% Upside)
2Ratings
0%
-25.50%
Abeona Therapeutics
Nov 11, 2020
Buy
Reiterated
$3.00
(-24.81% Downside)
4Ratings
0%
-29.40%
Krystal Biotech
Nov 11, 2020
Buy
Reiterated
$100.00
(29.03% Upside)
2Ratings
100%
+22.80%
Soligenix
Dec 04, 2020
Buy
Initiated
$4.00
(614.29% Upside)
1Ratings
0%
-68.00%
Viking Therapeutics
Aug 18, 2022
Buy
Reiterated
$20.00
(369.48% Upside)
5Ratings
60%
-8.52%
Immunocore Holdings
Aug 18, 2022
Buy
Reiterated
$85.00
(40.31% Upside)
2Ratings
100%
+35.60%
BELLUS Health
Aug 24, 2022
Buy
Reiterated
$20.00
(96.08% Upside)
15Ratings
89%
+84.79%
Bluebird Bio
Aug 25, 2022
Buy
Reiterated
$20.00
(135.57% Upside)
1Ratings
100%
+26.80%
Surface Oncology
Nov 02, 2022
Buy
Assigned
$6.00
(513.18% Upside)
11Ratings
0%
-64.10%
List of latest recommendations made by Justin Zelin. Click to expand and see Justin Zelin's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >